Monarch Disease Ontology identifier MONDO_0010162 (tyrosinemia type III) can be described as follows. Tyrosinemia type 3 is an inborn error of tyrosine metabolism characterized by mild hypertyrosinemia and increased urinary excretion of 4-hydroxyphenylpyruvate, 4-hydroxyphenyllactate and 4-hydroxyphenylacetate. Also known as: tyrosinemia due to 4-hydroxyphenylpyruvate dioxygenase deficiency, tyrosinemia due to 4-hydroxyphenylpyruvic acid oxidase deficiency, tyrosinemia due to HPD deficiency.